The overall goal of this project are to document the physiologic importance of the increased surface membrane expression of the types 1 and 3 complement receptors (CP1 and CR3) during activation of human neutrophils (PMN), and to determine the mechanisms of this process, specifically focusing on the hypothesis that receptor upregulation may occur without degranulation. Using immunoelectron microscopy, we have shown that CR1 in resting PMN is stored in unique vesicular structures that are clearly distinct from primary and secondary granules. In addition, quantitative immunofluorescence studies of fixed, permeabilized PMN suggest that upon activation by chemoattractants there is ligand- dependent internalization and degradation of CR1. Results of immunoassays of total CR1 in cell extracts are consistent with this proposal, and EM studies show that in activated cells the internal pool is in large multivesicular bodies. These findings can be integrated into an overall model for trafficking of CR1 and other proteins of interest during neutrophil activation. We will now test several hypotheses predicted by this model: 1> We will identify characterize a common storage pool for CR1, decay accelerating factor (DAF) and alkaline phosphatase in resting PMN. 2. We will determine if CR1 remains clustered and in association with the membrane segments with which it is brought to the cell surface while DAF and alkaline phosphatase, which are anchored by glycolipids, diffuse laterally. 3. We will study how CR1 and DAF are selectively packaged into their storage vesicles during in vitro differentiation of myeloid precursors. 4. We will document that CR1 that was expressed on the surface actually becomes internalized and characterize its degradation. 5. We will map the pathway of internalization of CR1 during ligand-independent recycling and compare this to endocytosis after crosslinking and ligand-dependent phagocytosis. The roles of clathrin and Ca++ in each of these processes will be defined. To accomplish these goals we will use the immunoelectron microscopic approach and other immunologic assays we have developed during the initial period of this grant. We will also study directly isolate the vesicles in which CR1 is stored by the use of antibodies against its cytoplasmic tail. These studies should yield much valuable information about the dynamics of receptor trafficking that allow phagocytes such as neutrophils to perform their vital roles in host defense.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022687-05
Application #
3134147
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1987-01-01
Project End
1995-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Chaudhuri, S; Kumar, A; Berger, M (2001) Association of ARF and Rabs with complement receptor type-1 storage vesicles in human neutrophils. J Leukoc Biol 70:669-76
Yoshida, Y; Kang, K; Berger, M et al. (1998) Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin. J Immunol 161:5873-9
Jost, C; Klickstein, L; Wetzler, E et al. (1998) Intracellular storage and regulated plasma membrane expression of human complement receptor type 1 in rat basophil leukemia cell transfectants. Blood 92:300-9
Kumar, A; Wetzler, E; Berger, M (1997) Isolation and characterization of complement receptor type 1 (CR1) storage vesicles from human neutrophils using antibodies to the cytoplasmic tail of CR1. Blood 89:4555-65
Tosi, M F; Zakem-Cloud, H; Demko, C A et al. (1995) Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection. J Infect Dis 172:453-61
Sengelov, H; Kjeldsen, L; Kroeze, W et al. (1994) Secretory vesicles are the intracellular reservoir of complement receptor 1 in human neutrophils. J Immunol 153:804-10
Berger, M; Wetzler, E; August, J T et al. (1994) Internalization of type 1 complement receptors and de novo multivesicular body formation during chemoattractant-induced endocytosis in human neutrophils. J Clin Invest 94:1113-25
Cowen, D S; Berger, M; Nuttle, L et al. (1991) Chronic treatment with P2-purinergic receptor agonists induces phenotypic modulation of the HL-60 and U937 human myelogenous leukemia cell lines. J Leukoc Biol 50:109-22
Berger, M; Wetzler, E M; Welter, E et al. (1991) Intracellular sites for storage and recycling of C3b receptors in human neutrophils. Proc Natl Acad Sci U S A 88:3019-23
Berger, M (1991) Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good? Clin Rev Allergy 9:119-42

Showing the most recent 10 out of 18 publications